Patent directory · USPTO A61K / A61P
Patents matching “antagonist”
678 pharma patents match "antagonist" in our USPTO index (A61K/A61P) — applicant, grant date, expiration, and drug links.
Quick answer
This filtered view shows 678 pharmaceutical patents matching "antagonist" in our USPTO PatentsView index (CPC A61K/A61P). Search matches patent number, title, applicant, and CPC classification codes.
Patent results
-
US 12226417
Fatty liver disease treatment using glucocorticoid and mineralocorticoid receptor antagonists
granted -
US 12215105
HPK1 antagonists and uses thereof
granted -
US 2025034260
FCRN ANTAGONISTS FOR TREATMENT OF IGG-RELATED DISEASES AND DISORDERS
granted -
WO 2025023852
ANTAGONISTES DU RÉCEPTEUR DE L'OREXINE MORPHOLINE
granted -
WO 2025023851
ANTAGONISTES DU RÉCEPTEUR DE L'OREXINE MORPHOLINE
granted -
US 12208071
Glucagon receptor antagonists
granted -
US 12201673
Treatment of inflammatory conditions by delivery of interleukin-1 receptor antagonist fusion protein
granted -
US 12202832
Heterocyclic compounds having a calcium-sensing receptor antagonistic activity
granted -
US 12171758
Crystalline salt forms of kappa opioid receptor antagonist and products and methods related thereto
granted -
US 12162861
Dopamine D3 receptor selective antagonists/partial agonists; method of making; and use thereof
granted -
US 12152038
Vasopressin receptor antagonists and products and methods related thereto
granted -
US 12134609
Quinoline cGAS antagonist compounds
granted -
US 12115255
Methods of use of emulsion formulations of an NK-1 receptor antagonist
granted -
US 12115166
Corticotropin releasing factor receptor antagonists
granted -
US 12115254
Methods of use of emulsion formulations of an NK-1 receptor antagonist
granted -
US 12102640
Use of dopamine and serotonin receptor antagonists for treatment in a subject with retinal degeneration
granted -
US 12098141
Bicyclic indazole glucocorticoid receptor antagonists
granted -
US 12097196
Dopamine D3 receptor selective antagonists/partial agonists and uses thereof
granted -
US 12098144
Piperazine indazole glucocorticoid receptor antagonists
granted -
US 12091387
Quinoline cGAS antagonist compounds
granted -
US 12090201
Methods for treating atopic dermatitis by administering an IL-4R antagonist antibody
granted -
US 12071442
Substituted pyrrolo[3,4-c]pyridines as HPK1 antagonists
granted -
US 12064433
Pyridone A2R antagonists
granted -
US 12065416
cGAS antagonist compounds
granted